» Articles » PMID: 36940196

Identification of Molecularly Unique Tumor-associated Mesenchymal Stromal Cells in Breast Cancer Patients

Overview
Journal PLoS One
Date 2023 Mar 20
PMID 36940196
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor microenvironment is a complex mixture of cell types that bi-directionally interact and influence tumor initiation, progression, recurrence, and patient survival. Mesenchymal stromal cells (MSCs) of the tumor microenvironment engage in crosstalk with cancer cells to mediate epigenetic control of gene expression. We identified CD90+ MSCs residing in the tumor microenvironment of patients with invasive breast cancer that exhibit a unique gene expression signature. Single-cell transcriptional analysis of these MSCs in tumor-associated stroma identified a distinct subpopulation characterized by increased expression of genes functionally related to extracellular matrix signaling. Blocking the TGFβ pathway reveals that these cells directly contribute to cancer cell proliferation. Our findings provide novel insight into communication between breast cancer cells and MSCs that are consistent with an epithelial to mesenchymal transition and acquisition of competency for compromised control of proliferation, mobility, motility, and phenotype.

Citing Articles

Patient-Derived Organoids Recapitulate Pathological Intrinsic and Phenotypic Features of Fibrous Dysplasia.

Kim H, Charton C, Shim J, Lim S, Kim J, Lee S Cells. 2024; 13(9.

PMID: 38727265 PMC: 11083396. DOI: 10.3390/cells13090729.


Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells.

Atiya H, Gorecki G, Garcia G, Frisbie L, Baruwal R, Coffman L Biomolecules. 2023; 13(11).

PMID: 38002286 PMC: 10669774. DOI: 10.3390/biom13111604.


Mesenchymal stem/stromal cells- a principal element for tumour microenvironment heterogeneity.

Sun L, Yao Y Front Immunol. 2023; 14:1274379.

PMID: 37885883 PMC: 10599013. DOI: 10.3389/fimmu.2023.1274379.

References
1.
Wei S, Fattet L, Tsai J, Guo Y, Pai V, Majeski H . Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat Cell Biol. 2015; 17(5):678-88. PMC: 4452027. DOI: 10.1038/ncb3157. View

2.
Xu Q, Wang L, Li H, Han Q, Li J, Qu X . Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β. Int J Oncol. 2012; 41(3):959-68. DOI: 10.3892/ijo.2012.1541. View

3.
Rivas E, Linares J, Zwick M, Gomez-Llonin A, Guiu M, Labernadie A . Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors. Nat Commun. 2022; 13(1):5310. PMC: 9463158. DOI: 10.1038/s41467-022-32782-3. View

4.
Quintero-Fabian S, Arreola R, Becerril-Villanueva E, Torres-Romero J, Arana-Argaez V, Lara-Riegos J . Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Front Oncol. 2020; 9:1370. PMC: 6915110. DOI: 10.3389/fonc.2019.01370. View

5.
McGuire J, Frieling J, Lo C, Li T, Muhammad A, Lawrence H . Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. Nat Commun. 2021; 12(1):723. PMC: 7851397. DOI: 10.1038/s41467-021-20962-6. View